Free Ad Diagnosis Tool vs Semrush in 2026: free guided triage vs a broad search-marketing suite

Free Ad Diagnosis Tool is intentionally narrow. It starts with a practical problem such as high CPL, high CPC, poor lead quality, a performance drop, weak sales despite enough leads, or uncertainty about the issue. A user then chooses Google Ads or Meta Ads and follows an adaptive questionnaire. The result is more useful than a generic PPC checklist because the questions change around the reported problem and platform, helping a small advertiser decide whether to investigate traffic quality, qualification, conversion, tracking, creative, frequency, or the post-click path first.

Its Google Ads route can ask about campaign type, search intent, spend, clicks, leads, CPC, Quality Score, location targeting, conversion tracking, and landing-page clarity. The Meta route can ask about creative format, objective, audience, spend, impressions, reach, clicks, leads, frequency, and lead capture. For short video or Reels, three-second views and ThruPlays can produce directional hook and hold signals. The tool presents a health score, confidence percentage, likely first focus, funnel view, and up to four suggested checks from those entered inputs.

The price is $0, with no published paid tier and no account connection required. It can print a result and locally compare a later diagnosis with the last result, but it does not publish API access, integrations, shared workspaces, scheduled monitoring, multi-account management, or client reports. That is not a defect in a quick triage utility. It is a hard boundary: use the result to frame the next inspection in the actual platforms and analytics, never as a verified diagnosis or a reason to make bulk campaign changes.

Semrush is a far broader product than a one-campaign diagnostic. Its reviewed profile describes a digital-marketing platform for keyword research, technical site audits, backlink analysis, competitor benchmarking, content optimization, and paid-search intelligence. That makes it a plausible long-term home for an in-house search team or agency that needs research across a programme, rather than a two-minute decision aid for one campaign. The breadth is the reason to buy it, but it also means a user who wants only a first paid-media hypothesis will encounter far more product than they need.

The published Free tier allows 10 searches per day, which is enough to assess whether its data and workflow fit a team but not enough to run a real programme. The SEO Toolkit is listed at €134 per month or €112.52 per month billed annually. Semrush One Starter is listed at €190 monthly or €158.40 billed annually, while the higher Semrush One tiers are €286 monthly or €238 billed annually, then custom. The reviewed pricing record also lists the AI Visibility Toolkit at $99 per month per domain. Those are platform prices, not a claim that every tier includes every paid-ad capability.

Semrush is best approached as a shared research stack with onboarding and budget behind it. The reviewed profile documents API coverage for much of the platform, including keyword rankings, backlink data, domain analytics, and position tracking, plus white-label reporting. It does not document a directly connected equivalent to Free Ad Diagnosis Tool’s adaptive Google Ads and Meta Ads questionnaire. A team evaluating Semrush for the specifically named Advertising Toolkit should confirm current entitlement and coverage with Semrush before purchasing, rather than inferring those details from general platform pricing.